UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
32.33
+2.54 (8.53%)
Nov 19, 2026, 1:44 PM EST - Market open
UroGen Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $58 | Buy | Maintains | $58 | +79.40% | Nov 5, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Maintains $65 → $62 | Buy | Maintains | $65 → $62 | +91.77% | Nov 5, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $60 | Buy | Reiterates | $60 | +85.59% | Nov 5, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $58 → $56 | Buy | Maintains | $58 → $56 | +73.21% | Nov 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $75 | Buy | Reiterates | $75 | +131.98% | Nov 3, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $44 → $48 | Hold | Maintains | $44 → $48 | +48.47% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $50 → $60 | Buy | Reiterates | $50 → $60 | +85.59% | Aug 5, 2026 |